Autoplaque vs TruPlan
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is to quantitatively analyze coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for assessing a patient's overall atherosclerotic burden, predicting heart attack risk, and guiding medical treatment strategies for coronary artery disease. It provides detailed characterization of plaque and stenosis for comprehensive risk stratification.
View Autoplaque →Choose TruPlan if…
Choose TruPlan if your focus is on comprehensive pre-procedural planning and post-procedural follow-up specifically for Left Atrial Appendage Closure (LAAC) procedures. This software excels in providing AI-enabled left heart segmentation, automated LAA landing zone definition, and various simulation tools (TEE, ICE, Fluoroscopic) to optimize device selection and placement for LAAC interventions.
View TruPlan →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | TruPlan |
|---|---|---|
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Standalone software on desktop/laptop or server within hospital infrastructure with thick-client software on multiple desktops/laptops. It runs locally without an internet connection, though license key activation requires a direct internet connection. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TruPlanTruPlan emphasizes user-friendliness with explicit mentions of 'intuitive controls,' 'simple and user friendly,' 'easy to use,' and 'drag and drop' features, alongside MacOS compatibility. While Autoplaque is described as an 'interactive tool' with reviewable and editable segmentations, its documentation does not highlight ease of use as strongly.
Clinical Value
TruPlanBoth tools are FDA-cleared and offer significant clinical value in their respective specialties. Autoplaque provides quantitative plaque analysis for heart attack risk prediction, backed by extensive peer-reviewed research. TruPlan, however, demonstrates a more direct and quantifiable impact on procedural efficiency and outcomes for Left Atrial Appendage Closure (LAAC) procedures, with reported reductions in devices used, procedural time, and increased capacity.
Pricing & Value
TruPlanTruPlan offers greater pricing transparency, including potential no-cost access through Boston Scientific representatives and a flexible subscription model for its broader cvi42 platform. It also highlights clear reimbursement opportunities for AI-enabled plaque analysis with CPT code 75577. Autoplaque's pricing is not disclosed, making it difficult to assess its financial value proposition.
Enterprise Readiness
TruPlanTruPlan explicitly states HIPAA compliance and has a Business Associate Agreement (BAA), along with ISO 13485:2016 and MDSAP certifications, indicating a robust framework for enterprise deployment and regulatory adherence. Its on-premise server deployment option also supports better integration into hospital IT infrastructure. Autoplaque lacks explicit statements on BAA/HIPAA compliance, and its workstation-based deployment may be less scalable for large enterprises.
Innovation
TruPlanBoth are innovative AI tools. Autoplaque excels in automated, quantitative plaque analysis for broad cardiovascular risk prediction, including the characterization of dangerous plaque. TruPlan stands out with its comprehensive AI-enabled procedural planning and multi-modal simulations (TEE, ICE, Fluoroscopic), including a 'first-to-market ICE simulator,' offering a more integrated and advanced solution for a complex interventional procedure.
Support & Docs
TruPlanTruPlan provides clear support channels, including an email address and the ability to create support tickets, along with a comprehensive list of documentation such as user manuals, installation guides, and release notes. Additionally, it benefits from field support through Boston Scientific's clinical and sales representatives. Autoplaque lacks specific details on dedicated support channels and documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | TruPlan |
|---|---|---|
| Tool Name | Autoplaque | TruPlan |
| Company | Cedars-Sinai Medical Center: AIM | Circle Cardiovascular Imaging |
| Primary Application | Quantitative analysis of coronary plaques and luminal stenoses from CT angiography images | Pre-procedural planning and post-procedural follow-up of Left Atrial Appendage Closure (LAAC) procedures |
| Key Feature Example 1 | AI-powered quantitative analysis of atherosclerotic plaque | AI-enabled Left Heart Segmentation |
| Key Feature Example 2 | Automated vessel, plaque, and lumen segmentation | Automated LAA Landing Zone Definition |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and TruPlan.